Strengthening Families & Communities LLC’s Corcept Therapeutics CORT Stock Holding History

Strengthening Families & Communities LLC’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$261	Buy	+3	New	+$181	﹤0.01%	814

Other funds holding CORT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

Strengthening Families & Communities LLC's CORT Position: Q2 2026 in Review

Strengthening Families & Communities LLC opened a new position in Corcept Therapeutics (CORT) in Q2 2026: 3 shares worth $261. The stake represents ﹤0.01% of the portfolio and ranks #814 among its holdings.

239 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

Strengthening Families & Communities LLC held 3 shares of Corcept Therapeutics worth $261 as of Q2 2026.
Corcept Therapeutics was a new Strengthening Families & Communities LLC position in Q2 2026.
Corcept Therapeutics made up ﹤0.01% of Strengthening Families & Communities LLC's portfolio in Q2 2026, its #814 holding.
239 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Strengthening Families & Communities LLC's 13F filing for Q2 2026, filed 11 Aug 2026.